Spero Therapeutics Inc. (SPRO)
NASDAQ: SPRO
· Real-Time Price · USD
1.93
-0.05 (-2.53%)
At close: Aug 15, 2025, 3:59 PM
2.00
3.88%
After-hours: Aug 15, 2025, 07:31 PM EDT
Spero Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -53.6M | -69.76M | -68.57M | 3.51M | 17.45M | 23.4M | 22.81M | -1.61M | -10.08M | -26.85M | -46.41M | -102.43M | -113.27M | -103.16M | -89.76M | -79.1M | -75.52M | -74.44M |
Depreciation & Amortization | n/a | 2K | 2K | 40K | 148K | 254K | 367K | 458K | 607K | 793K | 869K | 931K | 822K | 676K | 646K | 646K | 689K | 731K |
Stock-Based Compensation | 5.93M | 7.33M | 7.79M | 8.29M | 8.04M | 7.79M | 7.93M | 8.43M | 8.63M | 8.09M | 9.12M | 9.55M | 9.78M | 10.62M | 9.43M | 7.87M | 6.74M | 5.79M |
Other Working Capital | 28.11M | 24.94M | 31.9M | -35.68M | -45.08M | -51.49M | -71.68M | 17.97M | 9.22M | 18.66M | 15.36M | -2.37M | 6.96M | 8.73M | 12.95M | 13.72M | 327K | -2.1M |
Other Non-Cash Items | -7.87M | 1.06M | 1.04M | 1.02M | 6.31M | 6.29M | 6.28M | 6.12M | 818K | 681K | 3.35M | 5.02M | 5M | 5.09M | 2.37M | 801K | 725K | 637K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -154K | -74K | 15K | 60K | 144K | 82K | -717K |
Change in Working Capital | 23.21M | 27.99M | 36.28M | -30.4M | -46.34M | -51.94M | -70.38M | 15.59M | 11.47M | 21.67M | 22.09M | 4.26M | 11.6M | 9.67M | 12.9M | 16.26M | -2.41M | -10.02M |
Operating Cash Flow | -32.33M | -33.38M | -23.44M | -17.54M | -14.38M | -14.2M | -32.99M | 28.98M | 12.11M | 7.64M | -7.73M | -79.56M | -83.56M | -77.09M | -64.35M | -53.38M | -69.69M | -78.02M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -129K | -129K | -129K | -129K | 39K | 39K | 39K | 39K | -12K | -63K | -78K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4M | 4M | 4M |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -26.97M | -26.97M | -26.97M | -53.94M | -57.28M | -58.31M | -67.89M | -43.91M | -55.33M | -58.3M | -48.72M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 60.78M | 60.78M | 110.65M | 121.55M | 67.78M | 85.83M | 56.45M | 51.55M | 46.55M | 32.5M | 30.5M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 258K | 129K | 50.13M | 50.13M | 49.87M | 50M | n/a | n/a | -4M | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 33.94M | 33.81M | 83.81M | 67.74M | 10.53M | 27.69M | -11.39M | 7.67M | -8.79M | -21.87M | -14.3M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1K | 1K | -54.25M | -54.06M | -6.19M | -5.61M | 48.81M | 48.68M | 1.61M | 1.15M | 1.1M |
Financial Cash Flow | n/a | n/a | n/a | 1K | 221K | 221K | 221K | 14.4M | 20.31M | -33.37M | -29.55M | 6.62M | 29.71M | 83.56M | 84.05M | 49.79M | 97.78M | 105M |
Net Cash Flow | -32.33M | -33.38M | -23.44M | -17.54M | -14.16M | -13.98M | -32.77M | 43.38M | 32.29M | 24.14M | -3.48M | -62.41M | -26.16M | -4.93M | 27.38M | -12.38M | 6.22M | 12.68M |
Free Cash Flow | -32.33M | -33.38M | -23.44M | -17.54M | -14.38M | -14.2M | -32.99M | 28.85M | 11.98M | 7.51M | -7.86M | -79.52M | -83.52M | -77.05M | -64.31M | -53.39M | -69.76M | -78.1M |